---
schema_version: "secwatch.filing_event.v1"
accession: "0001773751-25-000128"
form_type: "8-K"
ticker: "HIMS"
cik: "0001773751"
company_name: "Hims & Hers Health, Inc."
filed_at: "2025-04-21T23:59:59+00:00"
generated_at: "2026-05-23T10:27:55.461145+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Hims & Hers COO Melissa Baird to step down, transition to advisory role

## Summary
- Baird will remain as COO until successor is identified and fully up to speed.
- She intends to move into an advisory role under a long-term agreement post-transition.
- Effective date of departure not yet determined; announcement made April 21, 2025.

## SEC filing metadata
- accession: 0001773751-25-000128
- form_type: 8-K
- ticker: HIMS
- cik: 0001773751
- company_name: Hims & Hers Health, Inc.
- filed_at: 2025-04-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1773751/000177375125000128/0001773751-25-000128-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1773751/000177375125000128/hims-20250421.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001773751-25-000128
- JSON: https://secwatch.observer/filing/0001773751-25-000128.json
- Plain text: https://secwatch.observer/filing/0001773751-25-000128.txt

## Key facts
- Executive change
  Melissa Baird changed role as Chief Operating Officer at Hims & Hers Health, Inc..
  - Action: transitioned
  - Role: Chief Operating Officer
  source text: Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc. (the “Company”), announced her intention to transition into an advisory role with Hims & Hers in the coming months.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1773751/000177375125000128/0001773751-25-000128-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.